谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.
研究兴趣

论文共 646 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
EPCORE FL-2: Phase 3 Trial of Epcoritamab with Rituximab and Lenalidomide (R2) Vs Chemoimmunotherapy or R2 in Previously Untreated Follicular Lymphoma
Kim M. Linton,Philip Thompson, Stefano Luminari,Carla Casulo,Poliana Patah, Lingmin Zeng, J. P. Mei, Neha Dixit,Daniela Hoehn, Emmanuel Bachy
Journal of Clinical Oncologyno. 16_suppl (2024): TPS7084-TPS7084
引用0浏览0引用
0
0
Ending Endless Follow-Up for Low-Risk CLL
Philip A. Thompson
Blood Advancesno. 16 (2024): 4447-4448
引用0浏览0WOS引用
0
0
Pirtobrutinib, a Highly Selective, Non-Covalent (reversible) BTK Inhibitor in Patients with B-cell Malignancies: Analysis of the Richter Transformation Subgroup from the Multicentre, Open-Label, Phase 1/2 BRUIN Study
William G. Wierda, Nirav N. Shah, Chan Y. Cheah,David Lewis, Marc S. Hoffmann, Catherine C. Coombs, Nicole Lamanna,Shuo Ma,Deepa Jagadeesh,Talha Munir,Yucai Wang, Toby A. Eyre, Joanna M. Rhodes,Matthew McKinney, Ewa Lech-Maranda,Constantine S. Tam,Wojciech Jurczak,Koji Izutsu, Alvaro J. Alencar, Manish R. Patel,John F. Seymour, Jennifer A. Woyach,Philip A. Thompson,Paolo B. Abada, Caleb Ho, Samuel C. McNeely, Narasimha Marella, Bastien Nguyen, Chunxiao Wang, Amy S. Ruppert,Binoj Nair, Hui Liu, Donald E. Tsai,Lindsey E. Roeker, Paolo Ghia
LANCET HAEMATOLOGYno. 9 (2024): e682-e692
引用0浏览0引用
0
0
Pairing Obinutuzumab with Venetoclax in Relapsed CLL
Kerry A. Rogers,Philip A. Thompson
Leukemia & lymphoma/Leukemia and lymphomano. 5 (2024): 543-545
引用0浏览0WOS引用
0
0
加载更多
作者统计

#Papers: 646

#Citation: 24145

H-Index: 72

G-Index: 138

Sociability: 8

Diversity: 4

Activity: 123

  • 合作者
  • 学生
  • 导师
暂无相似学者，你可以通过学者研究领域进行搜索筛选
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn